Abcm Corporation (ABCM): Price and Financial Metrics
GET POWR RATINGS... FREE!
ABCM POWR Grades
- Growth is the dimension where ABCM ranks best; there it ranks ahead of 90.75% of US stocks.
- The strongest trend for ABCM is in Stability, which has been heading down over the past 177 days.
- ABCM's current lowest rank is in the Momentum metric (where it is better than 10.23% of US stocks).
ABCM Stock Summary
- ABCM's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.42 -- higher than only 4.99% of US-listed equities with positive expected earnings growth.
- The price/operating cash flow metric for ABCAM PLC is higher than 95.61% of stocks in our set with a positive cash flow.
- In terms of twelve month growth in earnings before interest and taxes, ABCAM PLC is reporting a growth rate of -549.94%; that's higher than merely 3.35% of US stocks.
- Stocks that are quantitatively similar to ABCM, based on their financial statements, market capitalization, and price volatility, are VOXX, SBFM, OLK, INVE, and CRSR.
- To check out ABCAM PLC's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001492074.
ABCM Stock Price Chart Interactive Chart >
ABCM Price/Volume Stats
Current price | $13.14 | 52-week high | $19.39 |
Prev. close | $13.23 | 52-week low | $12.54 |
Day low | $13.04 | Volume | 274,214 |
Day high | $13.32 | Avg. volume | 665,992 |
50-day MA | $14.79 | Dividend yield | N/A |
200-day MA | $15.14 | Market Cap | 3.01B |
Abcm Corporation (ABCM) Company Bio
Abcm Corporation operates rehabilitation centers, long-term care facilities, and independent and assisted living communities. The Company offers out-patient therapy, independent and assisted living, skilled nursing and rehabilitative care, dementia care, family respite care, respite services, and home care. ABCM serves patients throughout the United States.
Latest ABCM News From Around the Web
Below are the latest news stories about ABCAM PLC that investors may wish to consider to help them evaluate ABCM as an investment opportunity.
ABCAM PLC: Final results for the year ended 31 December 2022Abcam plc (Nasdaq: ABCM) ('Abcam', the 'Group' or the 'Company'), a global leader in the supply of life science research tools, today announces its results for the year ended 31 December 2022 (the 'period'). |
Abcam to Report Full Year Results on Monday, March 20, 2023Abcam plc (Nasdaq: ABCM) ("Abcam" or the "Company"), a global leader in the supply of life science research tools, will report its results for the year ended 31 December 2022 at 7.00 a.m. ET on 20 March 2023. |
ABCAM PLC: Trading UpdateAbcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following preliminary trading update for the year ending 31 December 2022. |
A biotechnology product supplier is shuttering its office in Milpitas and cutting 30 workersAbcam plans to shutter its Milpitas location about 17 months after it acquired BioVision, which operated there. |
10 Best Medical Stocks Under $20In this article, we discuss 10 best medical stocks under $20. If you want to see more stocks in this selection, check out 5 Best Medical Stocks Under $20. The healthcare industry has undergone a significant restructuring in the wake of the COVID-19 pandemic. There were multiple new healthcare trends in 2022 that have a […] |
ABCM Price Returns
1-mo | -7.85% |
3-mo | -15.06% |
6-mo | -10.18% |
1-year | -29.24% |
3-year | N/A |
5-year | N/A |
YTD | -15.55% |
2022 | -33.93% |
2021 | 9.28% |
2020 | N/A |
2019 | N/A |
2018 | N/A |
Loading social stream, please wait...